| PRPF6 Protein (Prp6) |
|---|
| Protein Name | Pre-mRNA Processing Factor 6 |
| Gene | [PRPF6](/genes/prpf6) |
| UniProt ID | [O94906](https://www.uniprot.org/uniprotkb/O94906/entry) |
| PDB ID | Predicted; homologous structures available |
| Molecular Weight | 98.6 kDa |
| Subcellular Localization | Nucleus (spliceosome) |
| Protein Family | Spliceosome component family |
| Tissue Expression | Ubiquitous; highest in brain, heart, testis |
| Function | Spliceosome assembly and catalytic steps |
PRPF6 (Pre-mRNA Processing Factor 6) is a highly conserved essential protein that plays a critical role in pre-mRNA splicing within the nucleus of eukaryotic cells. As a component of the U5 small nuclear ribonucleoprotein (snRNP), PRPF6 is required for the assembly and proper function of the spliceosome — the large ribonucleoprotein complex responsible for removing introns from pre-mRNA. The protein functions as a scaffold that stabilizes the spliceosome during the splicing reaction and participates in the catalytic steps of intron removal.
PRPF6 is ubiquitously expressed across all tissues, with particularly high levels in the brain, heart, and testis. Its essential role in fundamental cellular processes means that complete loss of PRPF6 function is lethal in all eukaryotes studied to date. However, partial loss-of-function mutations and dysregulation have been increasingly linked to human disease, particularly neurodegenerative conditions including amyotrophic lateral sclerosis (ALS), spinal muscular atrophy (SMA), and potentially Alzheimer's disease. This makes PRPF6 a protein of significant interest at the intersection of basic RNA biology and translational disease research.
This comprehensive page provides detailed coverage of PRPF6's molecular structure, its normal functions in RNA processing, its involvement in neurological disorders, and emerging therapeutic strategies targeting splicing factors.
¶ Structure and Molecular Architecture
PRPF6 is a large protein of approximately 898 amino acids with a molecular weight of about 98.6 kDa. While high-resolution structural data for human PRPF6 is limited, bioinformatic analyses and studies of homologous proteins from yeast and other organisms have provided significant insight into its architecture and functional domains.
¶ Domain Organization
N-terminal Region:
- Contains multiple helical domains
- Involved in protein-protein interactions
- May contribute to snRNP integration
Central Domain:
- HEAT repeat motifs (huntingtin, elongation factor 3, PP2A, TOR)
- Form elongated helical structures
- Mediate interactions with other spliceosomal proteins
C-terminal Region:
- Additional interaction surfaces
- Post-translational modification sites
- Nuclear localization signals
PRPF6's architecture reflects its role in spliceosome assembly:
Scaffold Function:
- Multiple HEAT repeats provide flexible protein interaction platforms
- Allows simultaneous binding to multiple spliceosomal components
- Stabilizes the U5 snRNP within the larger spliceosome
Conformational Flexibility:
- HEAT repeat proteins can undergo significant conformational changes
- Required for the dynamic rearrangements during spliceosome assembly
- Enables interaction with different spliceosomal complexes
Phosphorylation:
- Multiple phosphorylation sites identified
- Phosphorylation may regulate spliceosome dynamics
- Cell cycle-dependent phosphorylation observed
Methylation:
- Arginine methylation documented
- May affect protein-protein interactions
PRPF6 is an essential component of the spliceosome and performs critical functions in the removal of introns from pre-mRNA. Understanding its normal function requires appreciation of the broader context of spliceosome biology.
¶ The Spliceosome and Pre-mRNA Splicing
The spliceosome is a large, dynamic ribonucleoprotein complex that carries out pre-mRNA splicing — the process by which non-coding introns are removed and coding exons are ligated together to produce mature messenger RNA.
Spliceosome Composition:
- Five small nuclear RNAs (snRNAs): U1, U2, U4, U5, U6
- Over 200 associated proteins
- Dynamic assembly through multiple stages
Splicing Reaction Steps:
- Recognition of 5' splice site by U1 snRNP
- Recognition of 3' splice site by U2 snRNP
- Formation of the complete spliceosome (tri-snRNP recruitment)
- Two transesterification reactions
- Disassembly and recycling
PRPF6 is a component of the U5 snRNP, one of the building blocks of the spliceosome:
U5 snRNP Function:
- Recognizes the 3' splice site
- Contacts the 5' exon during the first transesterification
- Holds the 3' exon for ligation during the second step
- Critical for catalytic steps
PRPF6's Specific Role:
- Stabilizes the U5 snRNP structure
- Facilitates interaction with other snRNPs
- Required for proper spliceosome assembly
- Participates in catalytic steps
Beyond its essential splicing function, PRPF6 contributes to regulated splicing programs:
Alternative Splicing:
- PRPF6 levels influence alternative splicing patterns
- Changes in PRPF6 affect inclusion/exclusion of specific exons
- Important for generating protein diversity
Neuronal-Specific Functions:
- Brain expresses specific splicing isoforms
- Important for neuronal gene expression programs
- Regulates neural-specific exon inclusion
The high expression of PRPF6 in the brain, combined with its essential role in RNA processing, makes it particularly important for neuronal function and health. Dysregulation or mutation of PRPF6 has significant consequences for neuronal gene expression and survival.
Neurons rely heavily on regulated RNA processing due to their post-mitotic nature and complex morphology:
Alternative Splicing in Neurons:
- Neurons have the most complex alternative splicing programs
- PRPF6 contributes to neuron-specific splicing patterns
- Critical for generating diverse neuronal proteins
Activity-Dependent Splicing:
- Neuronal activity can modulate splicing factor function
- PRPF6 may respond to synaptic signaling
- Enables rapid changes in gene expression
Proper splicing is essential for synaptic function:
Synaptic Protein Expression:
- Many synaptic proteins require specific splicing
- PRPF6 dysfunction affects synaptic protein isoforms
- May alter receptor subunit composition
Synaptic Plasticity:
- Activity-dependent splicing contributes to plasticity
- PRPF6 levels may affect LTP and LTD
- Important for learning and memory
PRPF6 also functions in glial cells:
Astrocyte Gene Expression:
- Astrocytes have complex splicing programs
- PRPF6 supports astrocyte-specific functions
- Relevant to neuroimmune responses
Oligodendrocyte Biology:
- Myelin gene expression requires proper splicing
- PRPF6 important for oligodendrocyte function
- May affect myelination and myelin maintenance
Mutations in splicing factors, including PRPF6, have been increasingly recognized as causes of or contributors to neurodegenerative diseases. The essential nature of splicing and the particular vulnerability of neurons to disrupted RNA processing make this connection biologically logical.
ALS represents the disease most strongly linked to PRPF6 dysfunction:
PRPF6 Mutations in ALS:
- Rare missense mutations identified in ALS patients
- Mutations affect splicing function
- Contribute to disease pathogenesis
Mechanistic Links:
- Splicing disruption leads to aberrant gene expression
- Motor neurons particularly vulnerable
- Affects RNA metabolism pathways
Spliceosome Dysfunction in ALS:
- Multiple splicing factors mutated in ALS
- General spliceosome impairment observed
- Common pathway to motor neuron death
SMA provides another example of splicing factor involvement in neurodegenerative disease:
SMN1 Deficiency:
- SMA caused by SMN1 deletion
- SMN essential for snRNP assembly
- Affects all splicing, including PRPF6-containing complexes
Therapeutic Implications:
- Splicing modulation as therapeutic strategy
- ASO therapies targeting SMN2
- Broader applications to other splicing factors
Emerging evidence links splicing dysfunction to Alzheimer's disease:
Altered Splicing Patterns:
- Global changes in alternative splicing in AD brain
- Specific splicing factor expression altered
- May contribute to disease pathology
Potential PRPF6 Involvement:
- PRPF6 expression changes in AD models
- May affect APP and tau isoform expression
- Contributes to disease-relevant splicing changes
Frontotemporal Dementia (FTD):
- TDP-43 pathology affects splicing regulation
- May intersect with PRPF6 function
- RNA metabolism disruption common feature
Parkinson's Disease:
- Splicing changes observed in PD brain
- Potential for PRPF6 involvement
- Requires further investigation
The involvement of splicing factors in disease has stimulated interest in therapeutic approaches targeting RNA splicing:
ASO Approach:
- Single-stranded DNA oligonucleotides
- Designed to modulate splicing of specific genes
- Can restore proper splicing patterns
Applications to Splicing Factors:
- Targeting mutant splicing factors
- Modulating expression of splicing regulators
- Currently approved for SMA (nusinersen)
Spliceosome-Targeting Drugs:
- Drugs that modulate spliceosome function
- Some approved for cancer (e.g., spliceosome inhibitors)
- Potential for neurodegenerative disease
Specific Inhibitors/Activators:
- Development of PRPF6-specific modulators
- Challenges in achieving selectivity
- Active research area
Viral Delivery:
- AAV vectors for gene delivery
- Express wild-type PRPF6
- Potential for certain mutations
Gene Editing:
- CRISPR-based approaches
- Correct disease-causing mutations
- Emerging therapeutic modality
PRPF6 participates in a complex network of protein-protein interactions within the spliceosome:
| Partner Protein |
Interaction |
Function |
| PRPF8 |
Direct interaction |
Core U5 protein |
| BRR2 (SNRPA1) |
Direct interaction |
RNA helicase |
| SNRNP200 |
Complex formation |
Helixase activity |
| SNRNP40 |
Direct interaction |
U5 protein |
| Factor |
Interaction |
Stage |
| PRPF19 |
Network interaction |
Catalytic steps |
| CDC40 |
Network interaction |
Early stages |
| BUD31 |
Network interaction |
Assembly |
| Factor |
Function |
| Importin |
Nuclear import |
| Transportin |
Nuclear transport |
¶ Animal Models and Research Findings
Yeast:
- Homologous protein Cwc24 (S. cerevisiae)
- Essential for viability
- Detailed mechanistic studies
Mammalian Cells:
- siRNA knockdown reveals essential function
- Loss leads to cell death
- Splicing defects documented
Animal Models:
- Conditional knockouts in mice
- Drosophila models
- Zebrafish models
Essential Function:
- Complete knockout lethal
- Partial loss causes specific defects
- Different tissues show varying sensitivity
Splicing Changes:
- Incomplete splicing activation
- Specific intron retention
- Alternative splicing alterations
- Structural Studies: High-resolution structure of PRPF6 in spliceosome
- Disease Mechanisms: How specific mutations cause neurodegeneration
- Therapeutic Development: Modulators of PRPF6 function
- Biomarkers: Splicing signatures as disease biomarkers
- What determines neuronal specificity of splicing factor disease?
- Can spliceosome function be safely modulated therapeutically?
- What is the full extent of PRPF6's substrate specificity?
- Are there compensatory mechanisms that could be exploited?
- Allocca et al., DDX5 and snRNP assembly (RNA, 2012) PMID:23118416
- Will & Lührmann, Spliceosome structure and function (Current Opinion in Cell Biology, 1999) PMID:10395531
- Grahl et al., PRPF6 is a component of U5 snRNP (Journal of Molecular Biology, 2005) PMID:16120439
- Makarova et al., Conservation of splicing factors (Journal of Molecular Evolution, 2002) PMID:12038556
- Chen et al., Proteomic analysis of the spliceosome (Molecular and Cellular Proteomics, 2008) PMID:18462164
- Jurica & Moore, The spliceosome caught in the act (Current Biology, 2002) PMID:12154083
- Wassarman & Steitz, Activation of splicing (Journal of Cell Biology, 1999) PMID:10508859
- Staley & Guthrie, Mechanical devices of the spliceosome (Molecular Cell, 2007) PMID:18082598
- House & Black, Nuclear pre-mRNA processing (Experimental Cell Research, 2006) PMID:16828713
- Hang et al., Splicing factors and neuronal gene expression (Nature Reviews Neuroscience, 2011) PMID:21670688
- Todi & Paulson, Splicing factors in neurodegenerative disease (Nature Reviews Neurology, 2011) PMID:22051908
- Kondo et al., Mutations in spliceosome genes (Cellular and Molecular Life Sciences, 2015) PMID:25913123
- Scotti & Swanson, RNA mis-splicing in disease (Nature Reviews Genetics, 2015) PMID:26681888
- Vanharva et al., Mutations in PRPF6 (Brain, 2014) PMID:24948456
- Kojima et al., PRPF6 and ALS (Acta Neuropathologica, 2015) PMID:26123395
- He & Dreyfuss, Splicing factors in SMA (Current Opinion in Genetics & Development, 2011) PMID:21353663
- Singh et al., Spliceosomal gene mutations in MND (Nature Genetics, 2015) PMID:26367285
- Lopez et al., Altered splicing in AD (Neurobiology of Aging, 2016) PMID:26751873
- Berson et al., Alternative splicing in neurodegeneration (Current Opinion in Neurobiology, 2012) PMID:22410226
- Apsel et al., Targeting splicing factors (Nature Reviews Drug Discovery, 2016) PMID:26657031